Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma

NCT06959979 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT06959979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06959979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Phase 1
Overall status
Recruiting
Start date
November 25, 2024
Completion date
February 28, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medulloblastoma, childhood